Skip to content

ONCOMAR

Active Private limited companyfounded 2002active for 23 yearsSchoonzichtlaan 49, 3020 HerentKBO/BCE: BE 0479.073.102

Lifetime

20 annual accounts with figures on one time axis, 23 filings since 2003
peak of €405,310 in 2024
€337,073▼ 16.8%
peak of €257,252 in 2024
€213,802▼ 16.9%
peak of €1.2m in 2025
€1.2m▲ 22.5%
€143,727▼ 27.8%
Board1 name since 2002
1 director
Documentsfilings and deeds
28-07-20263 days before the deadline
2025micro format
Gross margin from €405,310 to €337,073Equity from €950,063 to €1.2mDebts from €199,039 to €143,727Cash from €292,629 to €127,588

Key points

from the 2025 annual accounts

Equity

€1.2m ▲ 22.5%

ONCOMAR has made a profit in every financial year since 2006.

Liquidity

17.20 was 5.57 in 2024

Short-term debts fell from €199,039 to €75,727.

Filings

23 annual accounts since 2003
AprilJune31 JulyOctober20102020

Seven of the last ten came late. The 2017 accounts came in latest, 31 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,147 companies had the same profile as ONCOMAR has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,912 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,147 companies, not a prediction for ONCOMAR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 17-12-2002
Board & ownership

Recent changes

Company renamed from DOKTER to ONCOMAR changes role from manager to director · Director discharge: · Gazette deed
Capital decrease of €113,400 to €18,600 The capital fell from €132,000 to €18,600 · General meeting of 28-09-2018 · Gazette deed
Capital increase of €113,400 to €132,000 The capital rose from €18,600 to €132,000 · Gazette deed
Incorporation published on 24-12-2002 · Gazette deed
All 39 events

Official details

Source: KBO
Status
Active since 17-12-2002Normal situation
Activity
“De vennootschap kan bovendien alle werkzaamheden en rechtshandelingen verrichten die van aard zijn rechtstreeks…” (deed in Dutch)From the articles, 4 activities1 activity on the establishment unit
Establishment unit
2.229.748.4033020 Herent, since 03-12-2002
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

≈ €680,000estimated
€1.3m▲ 13.8%
≈ 0.1 FTEestimated
Filing
Filed on 28-07-2026, 3 days before the end of the filing period
Financials

Insights on ONCOMAR

ONCOMAR files the micro format. That format states no turnover. The gross margin rose from €171,320 in 2006 to €337,073 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ONCOMAR

What is the company number of ONCOMAR?
The company number of ONCOMAR is 0479.073.102. The VAT number is the same number with BE in front: BE 0479.073.102.
Where is ONCOMAR based?
The registered office is at Schoonzichtlaan 49, 3020 Herent.Company details
What is the legal form of ONCOMAR?
ONCOMAR is a private limited company (BV).
When was ONCOMAR founded?
ONCOMAR was founded on 17-12-2002.
Is ONCOMAR still active?
Yes, ONCOMAR is an active enterprise in the KBO register.
What is the turnover of ONCOMAR?
The turnover in financial year 2025 is ≈ €680,000. This figure is estimated from the gross margin of €337,073 and 1,019 comparable companies of the same size. It probably lies between €470,000 and €990,000. It is a rough estimate.Financials
Is ONCOMAR profitable?
In financial year 2025, ONCOMAR made a profit of €213,802.
Where can I find the annual accounts of ONCOMAR?
ONCOMAR filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ONCOMAR due?
ONCOMAR must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.